CERO THERAPEUTICS HOLDINGS, INC. Variable Lease, Cost
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Variable Lease, Cost of $201.82 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. variable lease, cost for the quarter ending 2026-06-30 was $201.82K, a 10.25% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. variable lease, cost for the quarter ending 2026-03-31 was $65.00K, a 65.38% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. variable lease, cost for the quarter ending 2025-09-30 was $187.73K, a 6.03% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. variable lease, cost for the quarter ending 2025-06-30 was $224.87K, a 28.98% increase year-over-year.
| Period end | Variable Lease, Cost 1 month | Variable Lease, Cost 2 month | Variable Lease, Cost 2 month as first filed | Variable Lease, Cost 3 month | Variable Lease, Cost 5 month | Variable Lease, Cost 6 month | Variable Lease, Cost 8 month | Variable Lease, Cost 9 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $201.82K 10-Q · filed 2026-08-14 | $266.82K 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | $65.00K 10-Q · filed 2026-05-15 | |||||||
| 2025-09-30 | $187.73K 10-Q · filed 2025-11-19 | $412.60K derived: sum of 2 quarters · filed 2026-08-14 | $600.33K 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | $224.87K 10-Q · filed 2026-08-14 | $412.60K 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | $187.73K 10-Q · filed 2026-05-15 | |||||||
| 2024-09-30 | $177.06K 10-Q · filed 2025-11-19 | $351.40K derived: sum of 2 quarters · filed 2025-11-19 | $441.56K 10-Q · filed 2025-11-19 | |||||
| 2024-06-30 | $174.35K 10-Q · filed 2025-08-22 | $264.50K 10-Q · filed 2025-08-22 | ||||||
| 2024-03-31 | $58.19K 10-Q · filed 2025-05-15 | $90.16K 10-Q · filed 2024-05-17 | ||||||
| 2024-02-13 | $84.40K 10-Q · filed 2025-11-19 | |||||||
| 2023-09-30 | $147.94K 10-Q/A · filed 2024-11-20 | $488.87K 10-Q/A · filed 2024-11-20 | ||||||
| 2023-03-31 | $147.96K 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |